
Mayo Clinic Ventures is the corporate venture capital and technology commercialization arm of Mayo Clinic, based in Rochester, Minnesota. It commercializes innovations arising from Mayo Clinic research through licensing, startup formation, and equity investments, supported by a $100 million venture and growth fund.
43% of their portfolio is in Healthcare. Deal activity decreased year-over-year (3 deals in the last 12 months vs 7 prior). Average disclosed round size is $55.7M (across 54 rounds with reported amounts).
Portfolio
48
Fund Size
$100M
Top Stage
Series B
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
60 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $56M | Aug 2026 | |
| Series G | $575M | Mar 2026 | |
| Series G | $575M | Jan 2026 | |
| LLin Health | Series A | $11M | Dec 2025 |
| Series A | $24M | Oct 2025 | |
| Seed | $3M | Feb 2025 | |
| Series A | $17M | Jan 2025 | |
| DDelfina Care | Series A | — | Jan 2025 |
| Series A | $17M | Jan 2025 | |
| Series B | $34M | Oct 2024 | |
| Series C | $88M | Jun 2024 | |
| Series B | $100M | Apr 2024 | |
| Seed | $2.4M | Aug 2023 | |
| Pre-Seed | $2.4M | Aug 2023 | |
| Series A | $30M | Jul 2023 | |
| Series A | — | Jun 2023 | |
| Series A | $20M | Jun 2023 | |
| Series B | $26M | May 2023 | |
| Series A | $15M | May 2023 | |
| Series A | — | Jan 2023 | |
| SSenda Biosciences | Series C | $123M | Aug 2022 |
| Series B | $45M | Jul 2022 | |
| Series A | $24M | Jul 2022 | |
| LLisa Health | Seed | $2.5M | Jul 2022 |
| Series C | $40M | Jun 2022 |
Page 1 of 3
Top Co-Investors
Canaan Partners8 shared
Kaiser Permanente Ventures6 shared
Khosla Ventures4 shared
Sequoia Capital4 shared
Illumina Ventures4 shared
General Catalyst3 shared
Alexandria Venture Investments3 shared
Flagship Pioneering3 shared
Qatar Investment Authority3 shared
Georgian Partners3 shared
Metrodora Ventures3 shared
Boutique Venture Partners3 shared
Bread & Butter Ventures3 shared
Tokio Marine Future Fund3 shared
Story Ventures3 shared
SemperVirens Venture Capital3 shared
Asahi Kasei3 shared
Fountain Healthcare Partners3 shared
Cota Capital3 shared
Emergent Medical Partners3 shared
Last updated: 7 September 2026